Detection and treatment of multidrug resistant TB in India remains lowBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5414 (Published 03 September 2013) Cite this as: BMJ 2013;347:f5414
- Cheryl Travasso
Only 6% of the estimated 66 000 cases of multidrug resistant tuberculosis (MDR-TB) in India in 2011 were detected, and only 5% of these patients were enrolled in second line treatment programmes, a study has found.
Although enrolment to treatment programmes of people in India with MDR-TB improved by over 50% a year between 2009 and 2011, the number of people being treated is still low in a country with one of the highest burdens of MDR-TB, says the report in Lancet Infectious Diseases.1
Mycobacterium tuberculosis is considered to be multidrug resistant when the strain is no longer sensitive to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial